BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23822826)

  • 1. Antileukotriene agents for the treatment of lung disease.
    Scott JP; Peters-Golden M
    Am J Respir Crit Care Med; 2013 Sep; 188(5):538-44. PubMed ID: 23822826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
    Leff AR
    Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on leukotrienes and their receptors with reference to asthma.
    Singh RK; Tandon R; Dastidar SG; Ray A
    J Asthma; 2013 Nov; 50(9):922-31. PubMed ID: 23859232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene modifiers for asthma treatment.
    Montuschi P; Peters-Golden ML
    Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
    Sharma JN; Mohammed LA
    Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
    Drazen JM
    Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological modulation of the leukotriene pathway in allergic airway disease.
    Montuschi P; Sala A; Dahlén SE; Folco G
    Drug Discov Today; 2007 May; 12(9-10):404-12. PubMed ID: 17467577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotrienes, antileukotrienes and asthma.
    Montuschi P
    Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene modifiers in the treatment of cardiovascular diseases.
    Riccioni G; Capra V; D'Orazio N; Bucciarelli T; Bazzano LA
    J Leukoc Biol; 2008 Dec; 84(6):1374-8. PubMed ID: 18794213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of leukotrienes and development of antileukotriene agents.
    Leff AR;
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6 Suppl 1):4-8. PubMed ID: 11426915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leukotriene modifiers].
    Minoguchi K; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antileukotriene drugs: a new treatment for asthma].
    Armetti L; Nicosia S
    Boll Chim Farm; 1999 Dec; 138(11):599-605. PubMed ID: 10765473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Leukotrienes and Leukotriene Modifiers in Asthma.
    Montuschi P
    Pharmaceuticals (Basel); 2010 Jun; 3(6):1792-1811. PubMed ID: 27713330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic properties of leukotriene receptor antagonists.
    Nicosia S
    Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileukotriene drugs: clinical application, effectiveness and safety.
    Riccioni G; Bucciarelli T; Mancini B; Di Ilio C; D'Orazio N
    Curr Med Chem; 2007; 14(18):1966-77. PubMed ID: 17691939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotrienes as mediators of asthma.
    Nicosia S; Capra V; Rovati GE
    Pulm Pharmacol Ther; 2001; 14(1):3-19. PubMed ID: 11162414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.